Glenzocimab
Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
Product Specifications
CAS Number
2101829-58-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7012630-01 0.02 mg
Recombinant Escherichia coli O127:H6 Protein CrcB homolog (crcB)
Ask
View Details MBS7012630-02 0.1 mg
Recombinant Escherichia coli O127:H6 Protein CrcB homolog (crcB)
Ask
View Details